These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27224425)

  • 1. Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III) n-butoxyethylpyridylporphyrin-based redox modifier.
    Weitzel DH; Tovmasyan A; Ashcraft KA; Boico A; Birer SR; Roy Choudhury K; Herndon J; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Batinic-Haberle I; Dewhirst MW
    Environ Mol Mutagen; 2016 Jun; 57(5):372-81. PubMed ID: 27224425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+.
    Weitzel DH; Tovmasyan A; Ashcraft KA; Rajic Z; Weitner T; Liu C; Li W; Buckley AF; Prasad MR; Young KH; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Herndon JE; Batinic-Haberle I; Dewhirst MW
    Mol Cancer Ther; 2015 Jan; 14(1):70-9. PubMed ID: 25319393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MnTnBuOE-2-PyP protects normal colorectal fibroblasts from radiation damage and simultaneously enhances radio/chemotherapeutic killing of colorectal cancer cells.
    Kosmacek EA; Chatterjee A; Tong Q; Lin C; Oberley-Deegan RE
    Oncotarget; 2016 Jun; 7(23):34532-45. PubMed ID: 27119354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
    Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
    Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer.
    Patel A; Kosmacek EA; Fisher KW; Goldner W; Oberley-Deegan RE
    Radiat Environ Biophys; 2020 Mar; 59(1):99-109. PubMed ID: 31728622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
    Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
    Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
    Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP
    Leu D; Spasojevic I; Nguyen H; Deng B; Tovmasyan A; Weitner T; Sampaio RS; Batinic-Haberle I; Huang TT
    Redox Biol; 2017 Aug; 12():864-871. PubMed ID: 28454069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
    Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
    Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
    Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.
    Yulyana Y; Tovmasyan A; Ho IA; Sia KC; Newman JP; Ng WH; Guo CM; Hui KM; Batinic-Haberle I; Lam PY
    Stem Cell Rev Rep; 2016 Feb; 12(1):140-55. PubMed ID: 26454429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment.
    McElroy T; Brown T; Kiffer F; Wang J; Byrum SD; Oberley-Deegan RE; Allen AR
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme.
    Lee DY; Chunta JL; Park SS; Huang J; Martinez AA; Grills IS; Krueger SA; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):978-85. PubMed ID: 23845846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concomitant radiotherapy with chemotherapy in patients with glioblastoma].
    Benouaich-Amiel A; Simon JM; Delattre JY
    Bull Cancer; 2005 Dec; 92(12):1065-72. PubMed ID: 16396752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP
    Chaiswing L; Yarana C; St Clair W; Tovmasyan A; Batinic-Haberle I; Spasojevic I; St Clair D
    Oxid Med Cell Longev; 2022; 2022():9664636. PubMed ID: 35898616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
    Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
    Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP
    Rajic Z; Tovmasyan A; de Santana OL; Peixoto IN; Spasojevic I; do Monte SA; Ventura E; Rebouças JS; Batinic-Haberle I
    J Inorg Biochem; 2017 Apr; 169():50-60. PubMed ID: 28131001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.